Tag: Environmental monitoring

Cleanroom Start-Up and Recovery Times: How to Justify and Document Them Cleanroom Start-Up and Recovery Times: A Step-by-Step Guide for GMP Compliance In the demanding field of aseptic manufacturing, contamination control is paramount to ensure sterility assurance and patient safety. The operation and maintenance of cleanrooms, especially those classified as grade A and B, require…

Read More “Cleanroom Start-Up and Recovery Times: How to Justify and Document Them” »

Cleanroom Start-Up and Recovery Times: How to Justify and Document Them Understanding and Implementing Cleanroom Start-Up and Recovery Times in Aseptic Manufacturing In pharmaceutical aseptic manufacturing, maintaining stringent contamination control is mandatory to ensure sterility assurance and product quality. A critical operational aspect is the management of cleanroom start-up and recovery times, which directly influence…

Read More “Cleanroom Start-Up and Recovery Times: How to Justify and Document Them” »

Component Preparation: Washing, Depyrogenation and Handling Under Annex 1 Component Preparation: Washing, Depyrogenation and Handling for Aseptic Manufacturing under Annex 1 Ensuring contamination control and sterility assurance during component preparation is a fundamental aspect of successful aseptic manufacturing. Compliance with Annex 1 of the EU GMP guidelines (and harmonized expectations globally) demands considered processes for…

Read More “Component Preparation: Washing, Depyrogenation and Handling Under Annex 1” »

Use and Qualification of Single-Use Systems in Aseptic Environments Step-by-Step Guide to Use and Qualification of Single-Use Systems in Aseptic Manufacturing Single-use systems (SUS) have become increasingly prevalent in pharmaceutical aseptic manufacturing due to their advantages in contamination control, process flexibility, and efficiency. However, their implementation in critical cleanroom environments requires rigorous qualification and strict…

Read More “Use and Qualification of Single-Use Systems in Aseptic Environments” »

RABS vs Isolators: Making the Right Technology Choice for Annex 1 Compliance RABS vs Isolators: Key Considerations for Annex 1 Contamination Control in Aseptic Manufacturing In the pharmaceutical industry, stringent contamination control is paramount for aseptic manufacturing processes, especially when adhering to Annex 1 requirements. Two prevalent technologies designed to enhance sterile manufacturing environments and…

Read More “RABS vs Isolators: Making the Right Technology Choice for Annex 1 Compliance” »

Isolator Leak Testing, Sanitization and Decontamination: Regulatory Expectations Isolator Leak Testing, Sanitization and Decontamination: A Step-by-Step Guide for Annex 1 Compliance Isolators constitute a critical component of contamination control strategies within aseptic manufacturing environments, ensuring sterility assurance and protection of sterile products from environmental contaminants. The regulatory landscape governing isolator operation, including leak testing, sanitization,…

Read More “Isolator Leak Testing, Sanitization and Decontamination: Regulatory Expectations” »

Designing Aseptic Process Simulations (Media Fills) Under Annex 1 Step-by-Step Guide to Designing Aseptic Process Simulations (Media Fills) Under Annex 1 Aseptic manufacturing is critical for the production of sterile pharmaceutical products intended for parenteral administration. The need for stringent contamination control and thorough validation of aseptic processes is emphasized in regulatory frameworks such as…

Read More “Designing Aseptic Process Simulations (Media Fills) Under Annex 1” »

CCS for Non-Sterile Manufacturing: Is Annex 1 Still Relevant? Cleanroom Contamination Control Strategy (CCS) for Non-Sterile Manufacturing: Assessing the Relevance of Annex 1 In the pharmaceutical manufacturing landscape, contamination control remains paramount to ensure drug product quality and patient safety. While Annex 1 to the EU GMP guidelines specifically addresses aseptic manufacturing and sterilised medicinal…

Read More “CCS for Non-Sterile Manufacturing: Is Annex 1 Still Relevant?” »

Contamination Control for Terminally Sterilized Products: Focus Areas Beyond Sterilization Contamination Control for Terminally Sterilized Products: Comprehensive Guide Beyond Sterilization In sterile pharmaceutical manufacturing, terminal sterilization offers a robust method to ensure the sterility assurance of finished products. However, the regulatory guidelines including EU GMP Annex 1 emphasize that contamination control measures extend significantly beyond…

Read More “Contamination Control for Terminally Sterilized Products: Focus Areas Beyond Sterilization” »

Container Closure Integrity Testing (CCIT) as a Contamination Barrier Ensuring Aseptic Manufacturing Through Container Closure Integrity Testing Container Closure Integrity Testing (CCIT) is a cornerstone in pharmaceutical sterile manufacturing, providing a critical barrier against contamination and ensuring sterility assurance throughout product shelf life. This detailed step-by-step GMP tutorial explores how CCIT integrates into contamination control…

Read More “Container Closure Integrity Testing (CCIT) as a Contamination Barrier” »